CYAND - CYANOTECH CORP

0.4116
0.023   5.466%

Share volume: 3,404
Last Updated: 05-11-2026
Pharmaceutical Products/Medicinal Chemicals: 0.85%

PREVIOUS CLOSE
CHG
CHG%
$0.39
0.02
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
72%
Profitability 75%
Dept financing 50%
Liquidity 30%
Performance 85%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
22.54%
3 Months
17.60%
6 Months
28.63%
1 Year
27.83%
2 Year
17.60%
Key data
Stock price
$0.41
P/E Ratio 
0.00
DAY RANGE
$0.34 - $0.41
EPS 
-$0.29
52 WEEK RANGE
$0.21 - $0.57
52 WEEK CHANGE
$17.60
MARKET CAP 
2.200 M
YIELD 
N/A
SHARES OUTSTANDING 
7.392 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$3,404
AVERAGE 30 VOLUME 
$3,291
Company detail
CEO: Matthew Custer
Region: US
Website: cyanotech.com
Employees: 100
IPO year: 1993
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, and Hawaiian Spirulina Pacifica. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors.

Recent news